Transgene Biotek informs about standalone financial results

15 Mar 2017 Evaluate

Transgene Biotek has informed about Standalone Financial Results, Limited Review for the period ended December 31, 2016.

The above information is a part of company’s filings submitted to BSE.

Transgene Biotek Share Price

2.13 0.07 (3.40%)
01-Feb-2026 16:59 View Price Chart
Peers
Company Name CMP
Apollo Hospital Ent. 6931.90
Max Healthcare Inst 976.15
Narayana Hrudayalay 1801.75
Aster DM Healthcare 570.45
Global Health 1120.40
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×